MeSH term
Frequency | Condition_Probility | Adolescent | 7 | 0.0 |
Adult | 19 | 0.0 |
Aged | 3 | 0.0 |
Child | 7 | 0.0 |
Family Health | 3 | 0.0 |
Female | 19 | 0.0 |
Humans | 38 | 0.0 |
Hypokalemic Periodic Paralysis/*genetics | 2 | 100.0 |
Male | 21 | 0.0 |
Middle Aged | 7 | 0.0 |
Mutation | 6 | 0.0 |
Pedigree | 17 | 0.0 |
Research Support, Non-U.S. Gov't | 31 | 0.0 |
Sodium Channels/chemistry/*genetics | 2 | 18.0 |
Animals | 9 | 0.0 |
Molecular Sequence Data | 19 | 0.0 |
Mutation/*physiology | 2 | 1.0 |
Sodium Channels/*genetics/metabolism | 5 | 41.0 |
Time Factors | 2 | 0.0 |
Age of Onset | 2 | 0.0 |
Codon/genetics | 2 | 0.0 |
DNA Mutational Analysis | 9 | 0.0 |
Phenotype | 10 | 0.0 |
Point Mutation/*genetics | 2 | 0.0 |
Cold/*adverse effects | 2 | 16.0 |
Polymorphism, Single-Stranded Conformational | 4 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 14 | 0.0 |
Amino Acid Sequence/genetics | 5 | 1.0 |
Amino Acid Substitution | 2 | 0.0 |
Electrophysiology | 2 | 0.0 |
Patch-Clamp Techniques | 2 | 0.0 |
Cold/adverse effects | 2 | 25.0 |
Point Mutation | 3 | 0.0 |
Sodium Channels/*genetics | 23 | 26.0 |
Electromyography | 3 | 1.0 |
Case-Control Studies | 2 | 0.0 |
Comparative Study | 4 | 0.0 |
Models, Molecular | 3 | 0.0 |
Paralyses, Familial Periodic/*genetics | 2 | 25.0 |
*Mutation | 4 | 0.0 |
Amino Acid Sequence | 8 | 0.0 |
Chromosome Mapping | 5 | 0.0 |
Cold | 2 | 1.0 |
Exons | 4 | 0.0 |
Linkage (Genetics) | 5 | 0.0 |
Muscle, Skeletal/*metabolism | 3 | 1.0 |
*Mutation, Missense | 2 | 0.0 |
Myotonia Congenita/*genetics | 5 | 38.0 |
Polymerase Chain Reaction | 5 | 0.0 |
Chromosomes, Human, Pair 17 | 5 | 1.0 |
Base Sequence | 14 | 0.0 |
DNA | 3 | 0.0 |
Growth Hormone/*genetics | 2 | 5.0 |
*Linkage (Genetics) | 3 | 0.0 |
Mice | 4 | 0.0 |
Rats | 2 | 0.0 |
Sequence Alignment | 4 | 0.0 |
Blotting, Southern | 3 | 0.0 |
Restriction Mapping | 2 | 0.0 |
Alleles | 2 | 0.0 |
Genotype | 3 | 0.0 |
*Point Mutation | 4 | 0.0 |
Glycine | 2 | 2.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Cell Line | 2 | 0.0 |
Organ Specificity | 2 | 0.0 |
Hyperkalemia/*genetics | 2 | 50.0 |
Polymorphism, Genetic | 5 | 0.0 |
*Chromosomes, Human, Pair 17 | 2 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
Muscles/*metabolism | 3 | 4.0 |
Paralyses, Familial Periodic/genetics/metabolism | 2 | 100.0 |
DNA/genetics | 3 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
Recombination, Genetic | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Muscles/*chemistry | 2 | 20.0 |
Sequence Homology, Nucleic Acid | 3 | 0.0 |
DNA Probes | 2 | 0.0 |
